OriGene Technologies Inc of Rockville, MD purchased the assets of Shenzhen P&A Biotech, a privately owned company that provides monoclonal antibodies to the research industry. OriGene will use the assets to establish a high throughput monoclonal antibody production outsourcing center in China. The company raised $6.5 million in private equity to finance the purchase. More details...